gene

IDUA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about IDUA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

31Connections
2Hypotheses
0Analyses
17Outgoing
14Incoming
0Experiments
0Debates

Summary

IDUA is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, implicated in, activates. Associated with Aging, Alzheimer, Ms. Connected to 10 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolIDUA
Full NameAlpha-L-iduronidase
Chromosome4p16.3
Protein TypeHydrolase
FunctionHeparan sulfate degradation: IDUA removes iduronic acid residues
Molecular Weight76 kDa
Amino Acids653 aa
UniProt IDP35475
NCBI Gene ID3419
Ensembl IDENSG00000127418
OMIM609014
GeneCardsIDUA
Human Protein AtlasIDUA
Acid-base catalysisResidues in the active site facilitate hydrolysis
Substrate specificityRecognizes the non-reducing end of heparan sulfate and dermatan sulfate
Associated Diseasesneurodegeneration
InteractionsTAU
KG Connections31 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: IDUA — AlphaFold P35475 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

IDUA Gene

gene · 1855 words

Pathway Diagram

graph TD
    IDUA["IDUA"]
    Alzheimer{"Alzheimer"}
    IDUA -->|"therapeutic target"| Alzheimer
    Aging{"Aging"}
    IDUA -->|"therapeutic target"| Aging
    Ms{"Ms"}
    IDUA -->|"therapeutic target"| Ms
    TAU["TAU"]
    IDUA -->|"activates"| TAU
    GRN["GRN"]
    IDUA -->|"therapeutic target"| GRN
    neurodegeneration["neurodegeneration"]
    IDUA -->|"implicated in"| neurodegeneration
    ACE["ACE"]
    ACE -->|"therapeutic target"| IDUA
    TREM2["TREM2"]
    TREM2 -->|"therapeutic target"| IDUA
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
    ALZHEIMER_S_DISEASE -->|"therapeutic target"| IDUA
    PILRA["PILRA"]
    PILRA -->|"therapeutic target"| IDUA
    style IDUA fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (17)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:IDUAdata_indataset_row0.00
ds-83b31ef18d49provides_data_fordataset1.00
Agingtherapeutic_targetdisease0.65
Mstherapeutic_targetdisease0.65
Inflammationregulatesdisease0.65

Incoming (14)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:IDUAdata_indataset_row0.00
ds-83b31ef18d49data_indataset1.00
GENESassociated_withgene0.60
INPP5Dassociated_withgene0.60
CTSDassociated_withgene0.60

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Residual Vascular Amyloid Prevents Complete CSF p-tau217 Nor 0.585 - Can CSF p-tau217 normalization serve as
Individual Baseline Variability in p-tau217 Half-Life Dictat 0.335 - Can CSF p-tau217 normalization serve as

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning IDUA in their description or question text

No additional research found